insights_auto
Why is MEOBF up 21,93%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
USDÂ 1,39
arrow_upward
+21,93%(+0,25) 1D
1 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
USDÂ 1,14
High
USDÂ 1,39
Low
USDÂ 1,14
Mkt. cap
1,83Â mjd
Avg. vol.
33,36Â k
Volume
11,42Â k
52-wk high
USDÂ 2,59
52-wk low
USDÂ 1,14
Beta
1,71
Shares outstanding
1,30Â mjd
No. of employees
108
Open
USDÂ 1,14
High
USDÂ 1,39
Low
USDÂ 1,14
Mkt. cap
1,83Â mjd
Avg. vol.
33,36Â k
Volume
11,42Â k
52-wk high
USDÂ 2,59
52-wk low
USDÂ 1,14
Beta
1,71
Shares outstanding
1,30Â mjd
No. of employees
108
News stories
From web sources and news partners
The Globe and Mail
·
26 minute gelede
Is a Microsoft Stock Split Coming After 23 Years?
MarketBeat
·
45 minute gelede
Arrow Financial Corporation (NASDAQ:AROW) Stock Has Consensus Target Price of $41.62 According to Brokerages
MarketBeat
·
45 minute gelede
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Stock Has Average Price Target of $18.20
WSJ
·
12 uur gelede
Nasdaq Leads Stocks Higher as Hiring Softens
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd